Collagen Cross-linking in Skeletal Aging and Disease
Collagen Cross-linking in Skeletal Aging and Disease
批准号:
8723061
负责人:
David R Eyre
金额:
$33.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 2015-07-31
关键词:
AdultAgeAgingArginineBiochemical MarkersBiological AssayBiological MarkersBone DensityBone ResorptionCartilageChemistryClinicalCollagenCollagen Type ICollagen Type IIIDegenerative polyarthritisDiseaseEnvironmental Risk FactorFailureFibril-Associated CollagensFibrillar CollagenGenerationsGeneticGoalsHealthHistidineHumanIminesIndividualJointsLinkLocationLongevityMass Spectrum AnalysisMeasuresMethodsMolecularMolecular TargetMonitorNatureOsteogenesis ImperfectaOsteoporosisPathway interactionsPatientsPeptidesPharmaceutical PreparationsPropertyProtein-Lysine 6-OxidaseProteinsProteomicsPublic HealthPyrrolesReactionRiskRisk FactorsRoleScientific Advances and AccomplishmentsSkeletonStructureTechniquesTestingThinkingTissuesUrineVertebratesadductarticular cartilagebasebonebone qualityclinically significantcrosslinkgene environment interactionindexinginterestmeetingsmolecular sitenovelosteoporosis with pathological fracturepublic health relevancepyridinolineskeletalskeletal tissuetheoriesurinary
中文摘要
描述(由申请人提供):我们正在研究胶原交联如何进化以适应人类骨骼,软骨和其他支持组织的独特功能。我们提出了一种结构,预测了骨胶原中吡咯交联的新化学和关键作用,并在软骨胶原中发现了一种以前未知的交联,精氨酸。我们提出并将寻求验证所有组织中纤维性胶原交联氧化成熟的统一理论。赖氨酸氧化酶的交联机制早在20世纪70年代就已被发现,但仍有许多未知之处。翻译后个体间胶原蛋白质量的差异,尤其是骨和软骨的交联化学差异,是骨质疏松性骨折和关节衰竭的潜在危险因素。它们是由累积的环境影响而不是直接的遗传基础造成的。我们正在通过使用先进的质谱蛋白质技术分析骨骼、软骨和其他骨骼组织胶原来实现这一目标。临床意义在于新的分子靶点有望满足骨质疏松症和骨关节炎的公共卫生挑战。骨骼组织在很大程度上依赖于高度专业化的胶原蛋白的交联,以获得其独特的强度、性能和寿命。因此,翻译的目的是寻找新的治疗分子靶点和基于尿胶原蛋白肽的非侵入性生物标志物,这些生物标志物可以指示患者的骨骼质量,关节软骨破裂率和其他骨骼健康指标。
英文摘要
DESCRIPTION (provided by applicant): We are studying how collagen cross-links have evolved to adapt human bone, cartilage and other supporting tissues for their distinctive functions. We have raised the structure which predicts a novel chemistry and critical role for pyrrole cross-links in bone collagen and identified a previously unknown cross-link, arginoline, in cartilage collagen. We propose and will seek to validate a unified theory of oxidative maturation for cross-links in the fibrillar collagens of all tissues. Though the lysyl oxidase cross-linking mechanism was discovered in the 1970s, much is still unknown. Post-translational differences in collagen quality between individuals, notably in the cross-linking chemistry of bone and cartilages, are potential risk factors for osteoporotic fracture and joint failure. They result from cumulative environmental influences rather than a direct genetic basis. We are pursuing this through analyses of bone, cartilage and other skeletal tissue collagens using advanced mass spectrometric protein techniques. The clinical significance is the promise of new molecular targets in the effort to meet the public health challenges of osteoporosis and osteoarthritis. Skeletal tissues depend heavily on the cross-linking of highly specialized collagens for their unique strengths, properties and longevity. The translational aim, therefore, is to seek new molecular targets for therapy and non- invasive biomarkers based on urinary collagen peptides that can index a patient's bone quality, joint cartilage breakdown rate and other measures of skeletal health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein Biochemistry Core
-
批准号:7245974
-
项目类别:
-
资助金额:$17.28万
-
财政年份:2007
-
负责人:David R Eyre
-
依托单位:
CONFERENCE ON BIOENGINEERING AND ORTHOPAEDIC SCIENCES
-
批准号:2080965
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1992
-
负责人:David R Eyre
-
依托单位:
PATHOLOGY OF INBORN SKELETAL DISEASES
-
批准号:3158032
-
项目类别:
-
资助金额:$4.39万
-
财政年份:1991
-
负责人:David R Eyre
-
依托单位:
PATHOLOGY OF INBORN SKELETAL DISEASES
-
批准号:3158031
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1989
-
负责人:David R Eyre
-
依托单位:
PATHOLOGY OF INBORN SKELETAL DISEASES
-
批准号:6532941
-
项目类别:
-
资助金额:$28.88万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
PATHOLOGY OF INBORN SKELETAL DISEASES
-
批准号:2633642
-
项目类别:
-
资助金额:$19.41万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
COLLAGEN CROSS-LINKING IN SKELETAL AGING AND DISEASE
-
批准号:7107318
-
项目类别:
-
资助金额:$33.41万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
BIOCHEMISTRY OF THE INTERVERTEBRAL DISC
-
批准号:3157733
-
项目类别:
-
资助金额:$17.73万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
BIOCHEMISTRY OF THE INTERVERTEBRAL DISC
-
批准号:3157730
-
项目类别:
-
资助金额:$17.48万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
COLLAGENS OF CARTILAGE AND THE INTERVERTEBRAL DISC
-
批准号:2909785
-
项目类别:
-
资助金额:$25.24万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
BIOCHEMISTRY OF THE INTERVERTEBRAL DISC
-
批准号:3157735
-
项目类别:
-
资助金额:$19.43万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
BIOCHEMISTRY OF INTERVERTEBRAL DISC
-
批准号:3157732
-
项目类别:
-
资助金额:$9.96万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
Collagen Diversity and Pathobiology in Skeletal Tissues
-
批准号:8274342
-
项目类别:
-
资助金额:$33.7万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
PATHOLOGY OF INBORN SKELETAL DISEASES
-
批准号:2079208
-
项目类别:
-
资助金额:$17.94万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
PATHOBIOLOGY OF INBORN SKELETAL DISEASES
-
批准号:3158035
-
项目类别:
-
资助金额:$15.52万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
PATHOLOGY OF INBORN SKELETAL DISEASES
-
批准号:3158030
-
项目类别:
-
资助金额:$18.2万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
PATHOLOGY OF INBORN SKELETAL DISEASES
-
批准号:3158036
-
项目类别:
-
资助金额:$21.0万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
Collagen Cross-linking in Skeletal Aging and Disease
-
批准号:8142218
-
项目类别:
-
资助金额:$33.7万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
Collagen Diversity and Pathobiology in Skeletal Tissues
-
批准号:8475425
-
项目类别:
-
资助金额:$32.01万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
Collagens of Cartilage and the Intervertebral Disc
-
批准号:6873592
-
项目类别:
-
资助金额:$34.49万
-
财政年份:1986
-
负责人:David R Eyre
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: